Replies to post #25877 on Radient Pharmaceuticals Corporation fka RXPC

[GetSeriousOK]

IF we finally get transparency, not WHEN.

I don't think we will ever hear another peep about RXPC or Radient. A stock cannot get deader than this. Tickers that are revoked simply do not get reinstated.

It doesn't matter whether Provista was going to merge with Radient in 2010. They didn't. It doesn't matter whether Radient signed an agreement with the Australians in 2003 or tried to sell DR-70 in Brazil in 1995 or hyped their test in England in 1999 -- none of that resulted in significant DR-70 sales.

And it REALLY doesn't matter whether Radient called AMDL a Subsidiary or a Division or a Branch or a Department. AMDL became worthless when the last DR70 patent expired.

Fast forward to TODAY: Radient and its Divisions/Subsidiaries/Departments/etc. have no assets and the company declared Insolvency which means the debt was NOT repaid. RXPC shares are worthless and they cannot be bought or sold. What else matters?

[dcspka]

So, Radient's next generation DR-70 kits are being readied for larger market penetration via Sunlong as we speak.

Of course, this is just a small sample of the overall usage DR-70 will provide the medical/diagnostic establishment. Sunlong simply provides the specialized research which various clients request. The actual product, specialized usage, and make-up still appears to be hush-hush at this time?

The behind-the-scene manipulations continue- sooner-or-later the formal announcements tying Radient to these various efforts and companies will have to take place.

By the Way, can it be established Who is the client which Sunlong has for this effort? They are not doing this on their own, being a research organization only.

I wonder who the business relationship is with in the United States- Provista perhaps?